Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
baseline Ipamorelin (Via GHS-R1a): Ghrelin receptor agonism in the pituitary/hypothalamus Synergy with GHRH: potentiates GH release 3-5x Somatostatin Inhibition (GHIH): Tonic Unlocking Pulse frequency: Physiological periodicity maintenance Selectivity: no cortisol effects (vs GHRP-2/6) Combined Pharmacokinetics: GH Liberation Profile: Pico GH: 90-120 minutes post combination administration Magnitude: 5-10x baseline levels (dose-dependent) Lift duration: 4-6 hours Secondary IGF-1: sustained increase 24-48h Applications, Mechanisms, and Extended Research 1
Both compounds are sold strictly for research purposes
What are the side effects of ipamorelin vs sermorelin
Biochimica et Biophysica Acta (BBA)-Biomembranes, 815(2), 184-188 Park, E
Vas inflamatorias : reduce expresin de TNF-, IL-1 e IL-6 en modelos de inflamacin aguda, sin inmunosupresin sistmica
